A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: The Bosentan Patient Registry
收藏Digital Science - Figshare2026-03-27 更新2026-03-28 收录
下载链接：
https://curate.curtin.edu.au/articles/journal_contribution/A_new_model_to_evaluate_the_long-term_cost_effectiveness_of_orphan_and_highly_specialised_drugs_following_listing_on_the_Australian_Pharmaceutical_Benefits_Scheme_The_Bosentan_Patient_Registry/31483645
下载链接
链接失效反馈官方服务：
资源简介：
A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: The Bosentan Patient Registry
创建时间：
2026-03-27
